Physician
Hematology
Dr. Kenneth Zuckerman, MD
|
|
Give Review
Doctor Kenneth Zuckerman, MD is an expert in the field of Hematology. He studied medicine at The Ohio State University College of Medicine. He over the years received 6 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Tampa Bay Magazine: Top Doctors", "Miami Metro City Guide: Top Doctors", "Top Doctors: Florida" and "Elected Member". Kenneth Zuckerman, MD is a published physician. He has 29 papers published. The most current publication "Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed event." Kenneth Zuckerman accepts Medicare.
Publications
- Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and Acute myeloid leukemia.
- Dichotomy between the release of bone marrow granulocytes and stem Cells.
- Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic Cell lines.
- Adult Chediak-Higashi parkinsonian Syndrome with dystonia.
- Chemotherapy of intermediate- and high-grade non-Hodgkin's Lymphomas with a high-dose doxorubicin-containing regimen.
- Chemotherapy of intermediate- and high-grade non-Hodgkin's Lymphomas with an intensive epirubicin-containing regimen.
- Clonality in juvenile chronic myelogenous Leukemia.
- Cloning and sequencing of an alternative splicing-derived cDNA variant of the GM-CSF receptor alpha subunit, which encodes a truncated protein.
- Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 Cells: a transformed event.
- The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNF-alpha to transduce a proliferative signal in the human megakaryoblastic leuk...
- Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human Myeloid leukemic cell line.
- Cloning and sequencing of the cDNAs encoding two alternative splicing-derived variants of the alpha subunit of the granulocyte-macrophage colony-stimulating factor rec...
- Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha -supported proliferation of Leukemia and lymphoma cell lines.
- Transforming growth factor: signal transduction pathways, Cell cycle mediation, and effects on hematopoiesis.
- Tumor necrosis factor-alpha-induced proliferation of human Mo7e leukemic Cells occurs via activation of nuclear factor kappaB transcription factor.
- An IkappaBalpha inhibitor causes Leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.
- Cell cycle and transcriptional control of human Myeloid leukemic cells by transforming growth factor beta.
- Transforming growth factor beta inhibits growth of more differentiated myeloid Leukemia cells and retinoblastoma protein phosphorylation at serine 795.
- Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid Leukemia cells.
- TNF-alpha-induced growth suppression of CD34+ Myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation.
- TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human Myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k).
- Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F com...
- Value of positron emission tomography scan in staging cancers, and an unusual presentation of Acute myeloid leukemia. Case 3. Acute myeloid leukemia presenting with ly...
- Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening.
- Gap junction mediated transport of shRNA between human embryonic stem Cells.
- TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid Leukemia cells.
- Using local solutions to address a national issue: ASP's recommendations to ensure the vitality of clinical research.
- Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced Cell cycle arrest.
Schools
Ohio State University College Of Medicine and Public Health
Ohio State University Hosps
Pb Brigham Hospital Harvard
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Tampa Bay Magazine: Top Doctors
- Miami Metro City Guide: Top Doctors
- Top Doctors: Florida
- Elected Member
Education
-
Brigham and Women's Hospital -
Ohio State University Hospital -
The Ohio State University College of Medicine
Hospital
-
Tampa General Hospital -
H. Lee Moffitt Cancer Center and Research Institute
Drug Facts
| NPI NUMBER | 1609883198 | |
| NPPES Provider LastName | ZUCKERMAN | |
| NPPES Provider FirstName | KENNETH | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology | |
| Total Claim Count | 124.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609883198 |
| Last Name Of The Provider | ZUCKERMAN |
| First Name Of The Provider | KENNETH |
| View All |
Similar Doctors
|
Dr. Michael T. Tees, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Marcie R. Tomblyn, MD |
|
Dr. Khaldoun Almhanna, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christopher B. George, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brian C. Betts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer E. Byer, MD |